Clinical Trial Detail

NCT ID NCT00602693
Title T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements no
Sponsors Masonic Cancer Center, University of Minnesota
Indications

marginal zone B-cell lymphoma

non-Hodgkin lymphoma

prolymphocytic leukemia

chronic lymphocytic leukemia

bone marrow cancer

multiple myeloma

Hodgkin's lymphoma

follicular lymphoma

chronic myeloid leukemia

acute leukemia

lymphoplasmacytic lymphoma

mantle cell lymphoma

Therapies

Sirolimus

Allopurinol + Cyclophosphamide + Fludarabine

Age Groups: adult

No variant requirements are available.